Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Heat shock proteins have been of clinical interest in therapeutic vaccination based on their ability to induce significant T- and B-cell responses against microbial pathogens and tumor antigens.

Therapeutic Vaccination for Dysplasia: Early Efficacy